The U.S. Food and Drug Administration (FDA) has been rocked by recent changes to several leadership roles while it has ...
The US Food and Drug Administration’s longtime oncology chief has filed to retire from the agency just weeks after he was ...
The move comes a day after Richard Pazdur, a top FDA official and Michele’s boss, announced his decision to retire.
Richard Pazdur, the US Food and Drug Administration’s lead drug regulator, plans to retire from the agency only weeks after ...
Newly appointed Center for Drug Evaluation and Research director Richard Pazdur has filed retirement papers with the ...
One day after the FDA’s new director of the Center for Drug Evaluation and Research (CDER), Richard Pazdur, M.D., informed ...
Nearly 90% of senior leaders who were at the FDA a year ago are no longer with the agency, a BioSpace analysis shows. None remain from the Office of the Commissioner.
George Tidmarsh and Vinay Prasad have taken leadership roles at CDER and CBER, respectively, impacting FDA's drug and ...
Food and Drug Administration Commissioner Marty Makary is under renewed scrutiny by Trump officials amid continued turmoil at ...
The U.S. Food and Drug Administration is moving Theresa Michele, longtime director of the office of non-prescription drugs, ...
LCDR Kavita C. Dada, Pharm.D., USPHS; CDR Mary E. Kremzner, Pharm.D., USPHS; Sanjeev K. Bhanot, Pharm.D.; Renu Lal, Pharm.D. A: The mission of CBER is to protect and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results